Publisher's Synopsis
This text presents insights into the emergent therapeutic strategies for stent drug delivery. Drug-eluting stents are poised to revolutionize the management of in-stent restenosis, which remains one of the most complex and intractable challenges to modern interventional cardiology. An understanding of the processes that lead to restenotic events is essential for cardiologists to make informed decisions on whether to use a drug-eluting stent, and which drug to select for their patients' conditions. Underpinning the biological process is the technology of the stent coating used to achieve controlled delivery of the chosen therapy.
